PDCD1 and autoimmune disease: However, patients with autoimmune diseases such as IBD have historically been excluded from clinical trials of ICIs, and there are few reports of programmed cell death protein-1 (PD-1) inhibitors administered to patients with a pre-existing form of IBD [13, 14].